Table 5.
Characteristics of MBC with positive SLNB.
| Study Year |
Mean tumor size (cm) | T stage (TNM | Tumor histology | Tumor grade | Positive ER | Positive PR | Positive Her2 | Ki67 <25% |
Mean SLN removed (n) | Mean ALN removed (n | Mean positive ALN (n) |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Albo 2003 |
1.7 | – | IDC (1) | Grade 2 (1) | 1 | 0 | 0 | – | 1 | 17 | 3 |
|
De Cicco 2004 |
– | T1 (6) | IDC (5) DCIS (1) |
Grade 1 (1) Grade 2 (3) Grade 3 (1) |
5 | 5 | – | 3 | 1 (1) | 23.6 (15–33) | 0.007 (0–1) |
|
Martin 2017 |
2.4 (5–4.0) | – | IDC (8) DCIS (1) |
Grade 1 (2) Grade 2 (6) Grade 3 (1) |
9 | 9 | 1 | 8 | 2.1 (1–5) | 15 (5–24) | 5.8 (0–24) |
IDC: Invasive Ductal Carcinoma; DCIS: Ductal Carcinoma in Situ; ER: Estrogen Receptor; PR: Progesterone Receptor; SLN: Sentinel Lymph Node; ALN: Axillary Lymph Node; -: data not available.